| Document |
Document Title |
|
WO/2023/082897A1 |
The present invention relates to a metal iridium complex and to an application thereof. The metal iridium compound has the general formula Ir(La)(Lb)(Lc), wherein La is the structure shown in formula (1), and Lb is the structure shown in...
|
|
WO/2023/071147A1 |
The present invention relates to the technical field of electronic materials, and specifically relates to a binuclear metal platinum complex and an organic electroluminescent device. The binuclear metal platinum complex provided by the p...
|
|
WO/2023/070761A1 |
Provided in the present invention is an iridium-based catalyst, which is characterized in that the chemical structural formula thereof is as shown in (I), wherein Ph is a phenyl, R is a methyl or ethyl, and X is one or more of CH3CO2, NO...
|
|
WO/2023/071719A1 |
The present invention relates to a platinum complex luminescent material and a use thereof. The platinum complex is a compound having the structure represented by chemical formula (I), the compound can be applied in organic light-emittin...
|
|
WO/2023/075192A1 |
The present invention relates to a chromium-based organic/inorganic hybrid nanoporous body including a fluorine-bearing organic ligand and a nitro- or amine-bearing organic ligand, a manufacturing method therefore, and a use thereof.
|
|
WO/2023/065614A1 |
The present invention relates to an organic metal complex, a mixture, a composition, an organic electronic component, an electronic device, and an application. The structure of the metal complex provided in the present invention comprise...
|
|
WO/2023/064664A1 |
Aqueous anticaking agent solutions are prepared by mixing a ferrous source, a citrate source, a hydroxide source and water together. The ferrous source and the citrate source are present in a Fe to citrate molar ratio of from 0.5 to 1.5 ...
|
|
WO/2023/061999A1 |
The present invention discloses a distinct mode of action of a nickel catalyst to forge C-0 bonds to unlock the mild utilization of N2O as O-atom transfer reagent in the synthesis of complex phenols from the corresponding aryl halides.
|
|
WO/2023/063112A1 |
The present disclosure provides an organic compound represented by general formula [1]. In formula [1], R1 and R2 are each independently selected from a hydrogen atom, an alkyl group, or the like. R3 are each independently selected from ...
|
|
WO/2023/057982A1 |
The present disclosure generally relates to the synthesis of an alkoxylated cannabinoid using a double metal cyanide (DMC) catalyst. This procedure affords a novel process for preparing water-dispersible and water-soluble versions of can...
|
|
WO/2023/056898A1 |
A cobalt-containing acidic amino acid complex and its use for treating cancer. In some embodiments, the cobalt-containing complex is represented by Formula I or II.
|
|
WO/2023/051134A1 |
The present invention relates to an organometallic iridium compound and an application thereof. The organometallic iridium compound has a general formula of Ir(La)(Lb)(Lc), wherein La has the structure as shown in formula (1), and Lb has...
|
|
WO/2023/056041A1 |
Catalyst materials for olefin metathesis reactions. The catalyst materials comprise a ruthenium phosphinimine complex. The ruthenium phosphinimine may be synthesized without bound N-heterocyclic carbene (NHC) or phosphine ligands, thereb...
|
|
WO/2023/046221A1 |
The present invention provides electroneutral cis-diiodidoplatinum(II) complexes with 1H-imidazole-derived ligands, a method of preparation thereof, and therapeutic use thereof, in particular for treating multiple myeloma. The complexes ...
|
|
WO/2023/047195A1 |
The present invention provides a new and improved method of forming Ferric maltol by reacting a Maltol in an organic alkaline solution/slurry with a non-carboxylate iron salt in an organic solvent. The present invention also provides an ...
|
|
WO/2023/014513A9 |
Methods of synthesizing crystalline metal -organic frameworks (MOFs) having polytopic organic linkers and. cations, where each linker is connected, to two or more cations, are provided. In the disclosed methods, the linkers are reacted w...
|
|
WO/2023/047007A1 |
The invention relates to the detection of acetic acid by means of a colour change in a water-soluble dinuclear palladacycle compound of formula [{Pd(R-C^N-SO3Na)(µ-AcO)}2], wherein R can be one of the following functional groups (H, OMe...
|
|
WO/2023/048084A1 |
The present invention provides an organic metal complex catalyst for an olefin metathesis reaction, which enables the achievement of a higher yield of a desired substance in an olefin metathesis reaction than the conventional catalysts. ...
|
|
WO/2023/042484A1 |
A compound represented by formula (1), a tautomer thereof, a colored composition, a dyed object, and dyed fabric and a method for producing the dyed fabric. [In formula (1), Ar1 and Ar2 are each a group represented by any of the formulae...
|
|
WO/2023/031525A1 |
The present invention relates to a process for hydrosilylating an unsaturated compound with a compound comprising at least one hydrogenosilyl function catalysed by organic cobalt compounds in the presence of a compound (E) having the for...
|
|
WO/2023/028644A1 |
The present application relates to a metal organic framework (MOF) glass composite comprising metal halide perovskite, and a method for its preparation.
|
|
WO/2023/025230A1 |
The present invention relates to a metal complex, an organic electroluminescent element, and a consumer product. By using the metal complex of the present invention as a light-emitting material, a green-to-red phosphorescent material hav...
|
|
WO/2023/021064A1 |
The Invention relates to a simple two-step method of making highly pure compounds of formula 1a with n being 1 or 2 and M being ruthenium or molybdenum and R being a linear or branched alkyl with 1 to 8 carbon atoms or a cyclic alkyl gro...
|
|
WO/2023/015526A1 |
The present disclosure provides a compound. The compound is a twin drug formed by a platinum drug and a small molecule drug that is covalently connected to the axial position of the platinum drug and has a negative immune modulation reli...
|
|
WO/2023/012393A1 |
The present invention relates to a cooling/heating method comprising the application and removal of a pressurising gas on a hybrid organic-inorganic porous material (MOF) whereby a breathing transition is produced. In this transition, a ...
|
|
WO/2023/012789A1 |
This invention is directed to iron-based complexes, and uses thereof for catalytic olefin metathesis reaction, including ring opening metathesis polymerization of olefins.
|
|
WO/2023/013949A1 |
The present invention relates to a ruthenium organometallic compound, a method for preparing same, and a method for manufacturing a thin film using same and, more specifically, to a ruthenium organometallic compound, a method for prepari...
|
|
WO/2023/008248A1 |
Provided is a reactive material that contains a compound represented by general formula (1) or (2). [Compound 1] (In formula (1), R1, R2, R3, and R4 each independently represent a hydrogen atom, a hydrocarbon group having 1-4 carbon at...
|
|
WO/2023/286589A1 |
Provided is a cobalt compound represented by general formula (1). (In the formula, R1-R7 each independently represent a hydrogen atom, a halogen atom, an alkyl group having 1-5 carbon atoms, a fluorine atom-including alkyl group having 1...
|
|
WO/2023/282200A1 |
The present invention provides a new porous porphyrin metal complex. The porphyrin metal complex according to the present invention can be used as, by utilizing the porosity thereof, a sensitive membrane that is highly sensitive and is f...
|
|
WO/2023/282138A1 |
The present disclosure provides an organic metal complex characterized by being represented by general formula (1). In general formula (1), M represents a metal atom and is selected from Ir, Pt, Os, Rh, Pd and Ru; R1 to R8 independently ...
|
|
WO/2023/281046A1 |
The present invention provides novel bispidone ligands and transition metal complexes thereof, especially iron and manganese complexes thereof. Furthermore, the present invention also relates to the use of said bispidone ligands and comp...
|
|
WO/2023/275422A1 |
Disclosed are: a mononuclear Ru(III) compound comprising two molecules of 2,2'-biimidazole as ligands; a method for obtaining same; and the therapeutic use thereof, preferably as an anti-carcinogenic agent. The cancer may be breast cance...
|
|
WO/2023/276543A1 |
The problem to be addressed by the present invention is to provide a toner, ink, printed matter, paint, coating, plastic, fiber, film, resist for black matrices, resist for photo spacers, and cured products of the preceding, by using, as...
|
|
WO/2023/276544A1 |
The problem to be solved by the present invention is to decolorize and solubilize a metal complex by easy methods using non-petroleum raw materials, thereby providing recyclable toners, inks, printed matter, paints, coatings, plastics, f...
|
|
WO/2022/269245A1 |
The specification describes hydrosiylation catalysts of Formula (Ia), (Ib), (Ic) and (Id). These catalysts show accelerated hydrosilylation activity in the presence of UV. Also described is the use of such catalysts in a hydrosilylation ...
|
|
WO/2022/266768A1 |
There is provided an iron-based complex of formula (IA) or (IB) or a solvate thereof (IA) (IB). The iron-based complex can be used for catalyzing a hydrosilylation reaction, such as the hydrosilylation of a ketone or an aldehyde. Also pr...
|
|
WO/2022/267941A1 |
Disclosed are an organometallic iridium compound and an application thereof. The organometallic iridium compound has the general formula of Ir(La)(Lb)(Lc), wherein La is the structure shown in formula (1) and Lb is the structure shown in...
|
|
WO/2022/262309A1 |
The present invention relates to an organometallic iridium compound and an application thereof. The organometallic iridium compound has a general formula of Ir(La)(Lb)(Lc), wherein La is the structure shown in formula (1), and Lb is the ...
|
|
WO/2022/263800A1 |
The invention relates to a process for synthesising organic molecules. The invention provides a process for forming an sp2-sp3 carbon-carbon bond between a first compound comprising a substituted or unsubstituted aromatic group and a sec...
|
|
WO/2022/262308A1 |
The present invention relates to a heterocyclic modified platinum complex containing an ONCN tetradentate ligand, which has the structure as shown in chemical formula (I). The described complex is used in organic light-emitting diodes, h...
|
|
WO/2022/262300A1 |
Disclosed in the present invention are a neutral iridium complex containing a biphenyl derivative ligand, a preparation method therefor and the application thereof in the preparation of an organic electronic device, in particular an orga...
|
|
WO/2022/261770A1 |
The present invention relates to a combination comprising a neurotensin receptor binding compound and FOLFIRINOX for use for the treatment of a neurotensin receptor overexpressing tumour in a subject.
|
|
WO/2022/262662A1 |
The present invention relates to an organometallic compound having a general formula Ir(La)(Lb)(Lc), and an application thereof. La is a structure represented by formula (1), and Lb is a structure represented by formula (2). The compound...
|
|
WO/2022/264759A1 |
The present disclosure provides an organic compound represented by the formula: M(L1)n(L2)m (wherein M represents a metal atom; n+m = 3; and n ≧ 1). M(L1) is represented by any one of general formulae [1] to [3], and M(L2) is represent...
|
|
WO/2022/256897A1 |
The present disclosure is directed to chelated nutrients having a structure [M(Ligand 1)(Ligand 2)]2Y, wherein: M is a metal selected from the group consisting of Cu, Mn, Zn, Co, Ni, Mg, Ca and Fe; Ligand 1 is glutamic acid; Ligand 2 is ...
|
|
WO/2022/253231A1 |
Platinum (II) complexes ( "Pt (II) complexes" ) that can emit in the red and/or deep red regions and methods of making and using thereof are described. These Pt (II) complexes can have dinuclearity with close Pt-Pt contact and close inte...
|
|
WO/2022/253221A1 |
Described herein are compounds containing palladium (II), as the central metal atom, and tetradentate [N^C^C^N] ligands. The compounds are charge neutral, and feature a donor-acceptor structure where a pendant substituted amino group (su...
|
|
WO/2022/256525A1 |
In an embodiment, the present disclosure pertains to a composition having a cation and an anion. In some embodiments, a base is incorporated into the anion, and the cation and the anion form a bifunctional catalyst. In some embodiments, ...
|
|
WO/2022/252360A1 |
Disclosed are a nickel polysulfide-mercaptobenzimidazole coordination compound and a preparation method therefor and an application thereof. The preparation method comprises the following steps: (1) dissolving a nickel salt and 2-mercapt...
|
